Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?

31 May 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endoplasmic Reticulum Stress and Disease
Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32536457
DOI: 10.1016/j.arcmed.2020.05.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?PMID 32536457Read ↗

Therapeutic potential of compounds targeting SARS-CoV-2 helicaseSemantic proximity Read ↗

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read ↗

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main proteaseSemantic proximity Read ↗

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease InhibitorsSemantic proximity Read ↗

The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19Semantic proximity Read ↗

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read ↗

Aptamers targeting SARS-COV-2: a promising tool to fight against COVID-19Semantic proximity Read ↗

Druggable targets and therapeutic development for COVID-19Semantic proximity Read ↗

Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus InfectionsSemantic proximity Read ↗

Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesSemantic proximity Read ↗

Molecular Mechanisms of the Medicines for COVID-19Semantic proximity Read ↗

Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 HelicaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.